E Fund Management Co., Ltd. Amicus Therapeutics, Inc. Transaction History

E Fund Management Co., Ltd.

$2.06 Billion
Q2 2025

A detailed history of E Fund Management Co., Ltd. transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, E Fund Management Co., Ltd. holds 46,326 shares of FOLD stock, worth $378,020. This represents 0.01% of its overall portfolio holdings.

Number of Shares

46,326

Previous 23,716 95.34%

Holding current value

$378,020

Previous $193,000 37.31%

% of portfolio

0.01%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$5.64 - $8.0 $127,520 - $180,880	22,610 Added 95.34%	46,326 $265,000
Q1 2025 May 12, 2025	BUY	$8.16 - $9.85 $171 - $206	21 Added 0.09%	23,716 $193,000
Q4 2024 Feb 06, 2025	SELL	$9.36 - $12.01 $23,137 - $29,688	-2,472 Reduced 9.45%	23,695 $223,000
Q3 2024 Nov 12, 2024	SELL	$9.55 - $12.09 $14,964 - $18,945	-1,567 Reduced 5.65%	26,167 $279,000
Q2 2024 Aug 12, 2024	SELL	$9.04 - $11.75 $67,781 - $88,101	-7,498 Reduced 21.28%	27,734 $275,000
Q1 2024 May 13, 2024	SELL	$11.43 - $14.24 $83,621 - $104,179	-7,316 Reduced 17.19%	35,232 $415,000
Q4 2023 Feb 06, 2024	BUY	$9.97 - $14.52 $61,524 - $89,602	6,171 Added 16.96%	42,548 $603,000
Q3 2023 Nov 13, 2023	BUY	$11.78 - $13.86 $17,787 - $20,928	1,510 Added 4.33%	36,377 $442,000
Q2 2023 Aug 11, 2023	BUY	$10.72 - $13.3 $11,888 - $14,749	1,109 Added 3.29%	34,867 $438,000
Q1 2023 May 11, 2023	SELL	$10.91 - $13.54 $26,216 - $32,536	-2,403 Reduced 6.65%	33,758 $374,000
Q4 2022 Feb 14, 2023	SELL	$9.89 - $12.7 $54,899 - $70,497	-5,551 Reduced 13.31%	36,161 $442,000
Q3 2022 Nov 14, 2022	SELL	$9.82 - $12.75 $105,339 - $136,769	-10,727 Reduced 20.46%	41,712 $435,000
Q2 2022 Aug 15, 2022	BUY	$6.23 - $11.12 $146,803 - $262,031	23,564 Added 81.61%	52,439 $563,000
Q1 2022 May 12, 2022	BUY	$7.89 - $12.48 $94,727 - $149,834	12,006 Added 71.17%	28,875 $273,000
Q4 2021 Feb 11, 2022	BUY	$9.82 - $12.44 $10,782 - $13,659	1,098 Added 6.96%	16,869 $195,000
Q3 2021 Nov 12, 2021	BUY	$8.74 - $11.84 $25,424 - $34,442	2,909 Added 22.62%	15,771 $151,000
Q1 2021 May 12, 2021	BUY	$9.2 - $23.86 $118,330 - $306,887	12,862 New	12,862 $127,000

Others Institutions Holding FOLD

# of Institutions

302

Shares Held

331M

Call Options Held

396K

Put Options Held

249K

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.29B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of E Fund Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on E Fund Management Co., Ltd. with notifications on news.

Account

E Fund Management Co., Ltd. Amicus Therapeutics, Inc. Transaction History